Marban Linda 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Jul 29, 2020
Insider Transaction Report
Form 4
Marban Linda
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2020-07-27$3.70/sh+41,497$153,539→ 62,367 total - Tax Payment
Common Stock
2020-07-27$9.81/sh−15,652$153,546→ 46,715 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-07-27−41,497→ 0 totalExercise: $3.70Exp: 2020-09-01→ Common Stock (41,497 underlying)
Holdings
- 309,915(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]920 shares of the Issuer's common stock are held by the Reporting Person in joint tenancy with her spouse.
- [F2]Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on July 27, 2020 of $9.81. The options would otherwise expire on September 1, 2020, pursuant to their terms.
- [F3]The Reporting Person disclaims beneficial ownership of these securities, in that she has no power to vote or to direct the voting of these securities, nor does she have the power to dispose of or to direct the disposition of these securities. This report shall not be deemed a disclaimer of any community interest of the Reporting Person in such securities.
- [F4]This option was previously reported as covering 414,971 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019.
- [F5]25% of the shares of common stock subject to this option vested immediately. 20% of the remaining shares of common stock subject to this option vested on each of September 1, 2011, September 1, 2012, September 1, 2013, January 1, 2014, and January 1, 2015.